• Prontosan Wound Gel X 50 g Highly Viscous Antimicrobial Wound Gel
1 1

B. Braun

Prontosan Wound Gel X 50 g Highly Viscous Antimicrobial Wound Gel

Prontosan Wound Gel X 50 g Highly Viscous Antimicrobial Wound Gel

$49.00 SGD
$0.00 SGD $49.00 SGD
促销 售罄
结账时计算的运费。
Clinical Summary: Prontosan Wound Gel X is a highly viscous antimicrobial wound gel manufactured by B. Braun containing 0.1% polihexanide (PHMB) and betaine surfactant for biofilm disruption and broad-spectrum antimicrobial activity. The gel provides sustained cleansing, moisturising, and decontamination of acute, chronic, and infected wounds between dressing changes. It is indicated for use on pressure ulcers, diabetic foot ulcers, surgical wounds, and burns requiring biofilm management and antimicrobial wound bed preparation.

Product Overview

Prontosan Wound Gel X is a CE-marked, highly viscous antimicrobial wound gel developed by B. Braun for the intensive management of acute and chronic wounds. The gel formulation combines two synergistic active components: polihexanide (PHMB) at 0.1% concentration, a broad-spectrum antimicrobial agent effective against gram-positive and gram-negative bacteria, yeasts, and biofilm-forming organisms including MRSA, VRE, and Pseudomonas aeruginosa; and betaine, an amphoteric surfactant that penetrates, disrupts, and removes established biofilm and wound debris from the wound bed.

The highly viscous gel matrix ensures prolonged contact time with the wound surface, maintaining antimicrobial and cleansing activity for extended periods between dressing changes. Prontosan Wound Gel X reduces wound odour, supports pain reduction at the wound site, and creates an optimal moist wound environment conducive to healing in stalled or complex wounds. The gel is compatible with a wide range of primary wound dressings and can be used in combination with Prontosan Wound Irrigation Solution for comprehensive wound bed preparation protocols.

Specifications

Manufacturer B. Braun Melsungen AG (Melsungen, Germany)
Product Prontosan Wound Gel X
REF / Article Number 400515 (50 g tube)
Composition Purified water, glycerol, hydroxyethylcellulose, betaine surfactant, 0.1% polihexanide (PHMB)
Antimicrobial Agent Polihexanide (PHMB) 0.1% — broad-spectrum activity against gram+/gram- bacteria, yeasts, MRSA, VRE, Pseudomonas
Surfactant Betaine — disrupts and removes biofilm and wound debris
Viscosity Highly viscous gel for prolonged wound contact
Sterility Non-sterile; for external wound use
Latex Content Latex-free
Regulatory CE marked (Class IIb medical device) under MDR 2017/745; manufactured under ISO 13485 quality management; compliant with EN 13727 antimicrobial efficacy standards
Packaging 50 g tube
Shelf Life Use within 8 weeks of opening; refer to packaging for expiry date

Clinical Indications and Key Applications

  • Biofilm disruption and antimicrobial management in chronic non-healing wounds including pressure ulcers (Stage II–IV) and venous leg ulcers
  • Wound bed preparation and decontamination of diabetic foot ulcers at risk of infection or biofilm colonisation
  • Management of acute surgical wounds with delayed healing or signs of critical colonisation
  • Treatment of partial-thickness and full-thickness burns requiring sustained antimicrobial wound coverage
  • Adjunctive wound care in traumatic wounds, abrasions, and lacerations with contamination risk
  • Odour reduction and pain management in malodorous or painful chronic wounds

Frequently Asked Questions

Q: How does polihexanide (PHMB) in Prontosan Wound Gel X differ from other wound antiseptics?
A: Polihexanide (PHMB) is a biguanide antimicrobial with broad-spectrum activity and a favourable cytotoxicity profile compared to older antiseptics such as povidone-iodine and chlorhexidine. Studies published in the Journal of Wound Care demonstrate that PHMB achieves effective antimicrobial concentrations while maintaining low tissue cytotoxicity, supporting wound cell proliferation. The European Wound Management Association (EWMA) position document on wound antiseptics recognises PHMB as a well-tolerated option for wound bioburden management.

Q: Can Prontosan Wound Gel X be used on infected wounds?
A: Yes. Prontosan Wound Gel X is indicated for use on acute, chronic, and infected wounds. The combination of PHMB antimicrobial activity and betaine surfactant biofilm disruption provides effective wound decontamination. However, for wounds with systemic signs of infection (fever, cellulitis, sepsis), systemic antibiotic therapy should be administered concurrently as directed by the treating clinician. Prontosan Wound Gel X is a topical adjunct and does not replace systemic antimicrobial treatment when indicated.

Q: How should Prontosan Wound Gel X be applied?
A: Apply a layer of gel approximately 3 mm thick directly to the wound bed after cleansing with Prontosan Wound Irrigation Solution or sterile saline. Cover with an appropriate secondary dressing. Reapply at each dressing change, typically every 1–3 days depending on wound exudate levels and clinical assessment. The gel maintains its antimicrobial and cleansing activity between dressing changes.

Q: Is Prontosan Wound Gel X compatible with other wound dressings?
A: Yes. Prontosan Wound Gel X is compatible with a wide range of primary and secondary wound dressings, including foam dressings, alginate dressings, hydrofibre dressings, and non-adherent contact layers. It should not be used with dressings containing oxidising agents (e.g., silver-releasing dressings that may interact with PHMB). Consult the dressing manufacturer's compatibility guidance when combining products.

Q: Where can I purchase Prontosan Wound Gel X in Singapore?
A: Prontosan Wound Gel X is available in Singapore through EMIS (Essential Medical International Supplies Pte Ltd), an authorised distributor of B. Braun wound care products. The product is classified as a Class IIb medical device and is available for purchase by healthcare facilities, wound care clinics, and individual consumers through emis.asia.

查看完整详细信息